EIF2AK3 and neoplasm: Consistent with the in vitro data, our in vivo results indicate that suppression of phospho-PERK, phospho-eIF2α, and eIF2α is closely correlated with the reduction of SMMC-7721 tumor xenografts, further supporting our notion.